Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
· 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
recurrent head and neck squamous cell carcinoma, metastatic head and neck squamous cell carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis
#885161
Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes
#885169
Plasma Rich in Growth Factors (PRGF-Endoret) in the Regeneration of Post-Extraction Sockets
#885160
Intensive Intervention to Improve Lifestyles in Subjects With Intermediate Cardiovascular Risk.
#885163
Morphological and Mechanical Assessment in the Achilles Tendon After Radiofrequency Stimulation in Runners
#885164
Record
· ID 854966
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.